10252018KNR2-2

You may have missed

Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon™ hGH in Pediatric Growth Hormone Deficiency

NCR Corporation Announces Timing and Additional Details Regarding its Previously Announced Separation

KBRA Assigns AA+ Rating, Stable Outlook to The City of New York’s General Obligation Bonds

Shaping Wealth Announces Inaugural BeFi Summit

NCR Corporation and NCR Atleos, LLC Announce Upsize and Pricing of Senior Secured Notes Offering

error: Content is protected !!